Table 3 Association of SCD with demographical and clinical variables: Multivariate logistic regression analyses
| Â | OR (95% CI) | p-value |
|---|---|---|
Age | 1.03 (0.99–1.08) | 0.131 |
Sex (male/female) | 0.88 (0.40–1.95) | 0.749 |
Episodic/chronic headache | 0.97 (0.17–5.43) | 0.968 |
Migraine types (with aura/without aura/chronic/probable) | 0.73 (0.35–1.51) | 0.392 |
Frequency of attacks per month | 1.02 (0.95–1.09) | 0.568 |
Maximum pain duration in hours | 0.994 (0.983–1.006) | 0.331 |
Number of tablets per month | 1.02 (0.95–1.09) | 0.590 |
Pain intensity on VAS | 1.14 (0.90–1.45) | 0.268 |
HIT-6 | 1.00 (0.94–1.07) | 0.887 |
K-MMSE | 1.02 (0.75–1.37) | 0.919 |
K-MoCA | 1.09 (0.85–1.38) | 0.507 |
GAD-7 | 0.96 (0.86–1.07) | 0.492 |
PHQ-9 | 1.31 (1.16–1.49) | <0.001 |
PSQI | 0.92 (0.82–1.03) | 0.161 |
Average Sleeping hours during weekdays | 0.66 (0.44–0.97) | 0.036 |
Average Sleeping hours during weekends | 1.02 (0.77–1.34) | 0.913 |